NDC 55379-405-30 - Hybrisil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55379-405
- Requested NDC
- 55379-405-30
- Package NDCs from labels
- 55379-405-30, 55379-405-31
- Manufacturer
- BioZone Laboratories, Inc.
- Effective date
- 2011-04-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hybrisil - BioZone Laboratories, Inc. | BioZone Laboratories, Inc. | 2011-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55379-405-31 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c55d-8e05-e053-dbdaa90a074a | f8432414-d8a6-4597-a226-61fd09a80e0c |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55379-405-30 | Hybrisil | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 2 | |
| 55379-405-31 | Hybrisil | 1 in 1 CARTON | GEL | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Methylprednisolone Acetate | ACTIVE INGREDIENT | 43502P7F0P | HYBRISIL (METHYLPREDNISOLONE ACETATE) GEL [BIOZONE LABORATORIES, INC.] | 2 | |
| Methylprednisolone | ACTIVE MOIETY | X4W7ZR7023 | HYBRISIL (METHYLPREDNISOLONE ACETATE) GEL [BIOZONE LABORATORIES, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Acetate | METHYLPREDNISOLONE ACETATE | Eugia US LLC | a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | 2026-04-21 | Warnings, Adverse reactions | 43502P7F0P |
| methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sportpharm LLC | 904b098c-9068-42ed-958f-6ab78ea42b1f | 2026-04-01 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone Acetate | METHYLPREDNISOLONE ACETATE | Caplin Steriles Limited | 23f98766-7571-49cb-8c1a-58fabba53965 | 2026-02-06 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sportpharm LLC | 62f4339a-a971-414d-b407-ef030fe4f989 | 2026-02-06 | Warnings, Adverse reactions | 43502P7F0P |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 823b0010-2b57-4e76-b5ac-4a8c2963438f | 2026-01-21 | Warnings, Adverse reactions | 43502P7F0P |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 9a7b3837-e038-48bf-97e9-78ad463760dc | 2026-01-21 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals NY LLC | 8ea42650-21cd-49e4-92c8-48f2eeaf95bc | 2026-01-19 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | 3184a75e-61c5-4281-abf0-4eab861ca009 | 2026-01-19 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | de12f38c-ffa1-4d62-b9cb-238a263f6fea | 2025-12-31 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | d944240d-2c19-46ba-ad4f-3fbee7b8629c | 2025-12-15 | Warnings, Adverse reactions | 43502P7F0P |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | bf1b104d-85cb-414d-a366-78068c82c883 | 2025-12-01 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | 1084208f-3b86-4aef-8247-5b6ed6cd50c7 | 2025-11-07 | Warnings, Adverse reactions | 43502P7F0P |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | cb457bef-8823-4f3c-987b-eb0922494c46 | 2025-11-06 | Warnings, Adverse reactions | 43502P7F0P |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | d75f6751-9ac3-416f-8470-6c011aacf755 | 2025-11-05 | Warnings, Adverse reactions | 43502P7F0P |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | e8209047-c1e6-4081-a6d3-c603d9ee4f14 | 2025-10-27 | Warnings, Adverse reactions | 43502P7F0P |
| methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sagent Pharmaceuticals | f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | 2025-03-02 | Warnings, Adverse reactions | 43502P7F0P |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | 2f47d739-c39f-47c2-9e3c-1aef2cf201b1 | 2024-06-03 | Warnings, Adverse reactions | 43502P7F0P |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | aa151d12-bd33-4d26-848f-2195172c9700 | 2024-06-03 | Warnings, Adverse reactions | 43502P7F0P |
| Medroloan SUIK | METHYLPREDNISOLONE ACETATE | Asclemed USA, Inc. | 7867127f-aab1-494f-8c3d-e521ed578c3a | 2022-12-09 | Warnings, Adverse reactions | 43502P7F0P |
| Medroloan II SUIK | METHYLPREDNISOLONE ACETATE | Asclemed USA, Inc. | 18dacdba-793c-490d-aa73-9e76bec41fae | 2022-12-09 | Warnings, Adverse reactions | 43502P7F0P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.